[Image courtesy of Cognito Therapeutics] Cognito Therapeutics announced this week that its Spectris treatment reduced the Alzheimer’s Disease Dependence Score by over 50% in a clinical trial.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, presented new data today at the 17th Clinical Trials ...

In a closed meeting with a limited number of journalists, DEM Party’s co-leaders discussed the recent talk of a potential new peace process with the Kurds ... İMC TV ve BirGün gazetesinde haber müdürü ...